Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
Phenylketonuria (PKU) is a genetic metabolic disease in which the decrease or loss of phenylalanine hydroxylase (PAH) activity results in elevated, neurotoxic levels of phenylalanine (Phe). Due to many obstacles, PAH enzyme replacement therapy is not currently an option. Treatment of PKU with an alt...
Main Authors: | Sean M Bell, Dan J Wendt, Yanhong Zhang, Timothy W Taylor, Shinong Long, Laurie Tsuruda, Bin Zhao, Phillip Laipis, Paul A Fitzpatrick |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5345807?pdf=render |
Similar Items
-
Biochemical Evaluation of Phenylalanine Ammonia Lyase from Endemic Plant Cyathobasis fruticulosa (Bunge) Aellen. for the Dietary Treatment of Phenylketonuria
by: Seda Şirin, et al.
Published: (2016-01-01) -
Tyrosine and phenylalanine ammonia lyases in Sporobolomyces roseus
by: Camm, Edith Ellen
Published: (2011) -
Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
by: Rui Tao, et al.
Published: (2020-12-01) -
Production of L-Phenylalanine with Phenylalanine Ammonia-Lyase Encapsulated by Emulsion Liquid Membrane
by: Lee, Cha Chen, et al.
Published: (1996) -
Genomic Characterization of Phenylalanine Ammonia Lyase Gene in Buckwheat.
by: Karthikeyan Thiyagarajan, et al.
Published: (2016-01-01)